Elisabeth S Gruber
6PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 10, 2025
Radiation-Enhanced AF1q Moves Center Stage as a Key Driver to Favorable Tumor Stage in Rectal Cancer Patients.Elisabeth S Gruber, Georg Oberhuber, Elisabeth Gurnhofer
|Dec 29, 2020
Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019, 8, 1357.Elisabeth S Gruber, Georg Oberhuber, Peter Birner
|Mar 04, 2020
The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue Microarray.Elisabeth S Gruber, Georg Oberhuber, Dietmar Pils
|Sep 27, 2019
Impact of Fibroblast-Derived SPARC on Invasiveness of Colorectal Cancer Cells.Daniel Drev, Felix Harpain, Andrea Beer
|May 07, 2019
Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.Elisabeth S Gruber, Gerd Jomrich, Dietmar Tamandl
|Feb 24, 2018
ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.Stefanie Schmidt, Neele Schumacher, Jeanette Schwarz
Pageof 1
Frequent Collaborators
2 joint publications
Gerd Jomrich
1 joint publications
Stefanie Schmidt
1 joint publications
Christoph Becker-Pauly
1 joint publications
Ashwini L Chand
1 joint publications
Jürgen Westermann
1 joint publications
Peter J Dempsey
1 joint publications
Christoph Garbers
1 joint publications
Dirk Schmidt-Arras
1 joint publications
Philip Rosenstiel
1 joint publications
Stefan Rose-John
